Prognostic Role of Elevated Myeloperoxidase in Patients with Acute Coronary Syndrome: A Systemic Review and Meta-Analysis
Background. Myocardial inflammation following acute ischemic injury has been linked to poor cardiac remodeling and heart failure. Many studies have linked myeloperoxidase (MPO), a neutrophil and inflammatory marker, to cardiac inflammation in the setting of acute coronary syndrome (ACS). However, th...
Saved in:
| Main Authors: | Andrew R. Kolodziej, Mohamed Abo-Aly, Eman Elsawalhy, Charles Campbell, Khaled M. Ziada, Ahmed Abdel-Latif |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2019/2872607 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Myeloperoxidase: A New Biomarker of Inflammation in Ischemic Heart Disease and Acute Coronary Syndromes
by: Valentina Loria, et al.
Published: (2008-01-01) -
The role and clinical significance of myeloperoxidase (MPO) and TNF-α in prognostic evaluation of T-COPD
by: E. Jiang, et al.
Published: (2025-04-01) -
Neutrophil myeloperoxidase index in pediatric acute appendicitis
by: Stanković Nikola, et al.
Published: (2019-01-01) -
Myeloperoxidase-Dependent LDL Modifications in Bloodstream Are Mainly Predicted by Angiotensin II, Adiponectin, and Myeloperoxidase Activity: A Cross-Sectional Study in Men
by: Karim Zouaoui Boudjeltia, et al.
Published: (2013-01-01) -
Role of myeloperoxidase in atrial fibrillation and ischemic heart disease
by: G. F. Bunenkova, et al.
Published: (2023-01-01)